Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo

Miki Tongu, Nanae Harashima, Hiroyuki Monma, +4

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceOncologyLow-dose CyclophosphamideMedicineMetronomic Therapy +8

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

Touko Inao, Yuichi Iida, Tamami Moritani, +4

Oncotarget

Breast OncologyApoptosisImmunologyCell DeathCancer Biology +15

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

Hirotaka Iwase, Yutaka Yamamoto, Mutsuko Yamamoto‐Ibusuki, +7

British Journal of Cancer

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Mai Tomiguchi, Yutaka Yamamoto, Mutsuko Yamamoto‐Ibusuki, +8

Cancer Science

Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer

Touko Inao, Nanae Harashima, Hiroyuki Monma, +5

Breast Cancer Research and Treatment

Breast OncologyCytoplasmic DeliveryMedicinePolymer-drug ConjugateImmunology +9

The HSP70 and Autophagy Inhibitor Pifithrin-μ Enhances the Antitumor Effects of TRAIL on Human Pancreatic Cancer

Hiroyuki Monma, Nanae Harashima, Touko Inao, +3

Molecular Cancer Therapeutics

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer

Hiroko Yamashita, Akiko Ogiya, Tadahiko Shien, +13

Breast Cancer

Breast OncologyMedicineClinicopathological FactorsGynecologyPathology +6

Different sensitivities of senescent breast cancer cells to immune cell‐mediated cytotoxicity

Touko Inao, Hitoshi Kotani, Yuichi Iida, +5

Cancer Science

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer

Yuichiro Miyoshi, Tadahiko Shien, Akiko Ogiya, +14

Oncology Letters

Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis

Yasunari Kawabata, Tsuneo Tanaka, Takashi Nishisaka, +3

Diagnostic Pathology